Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCEPT: CIR-NA in Prediabetes
NCT07286747Phase 2Recruiting
- Sponsor
- Universitätsklinikum Schleswig-Holstein
- Start
- Mar 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of controlled-ileal-release nicotinic acid in prediabetes, sponsored by Universitätsklinikum Schleswig-Holstein. Started Mar 2026; status: recruiting.
02
Drugs
controlled-ileal-release nicotinic acid
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT07286747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07286747.